PBMs have evaded lawmakers’ reform attempts so far. Could 2025 turn the tide?
PharmaVoice
JANUARY 6, 2025
How regulators could hit PBMs from multiple sides in the coming year.
PharmaVoice
JANUARY 6, 2025
How regulators could hit PBMs from multiple sides in the coming year.
PharmaTimes
JANUARY 6, 2025
IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer
MedCity News
JANUARY 2, 2025
Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions. The post FDA Wraps Up 2024 Handing Out Several Notable Regulatory Decisions appeared first on MedCity News.
Pharmaceutical Technology
JANUARY 2, 2025
Eli Lilly and Novo Nordisk have been competing in the obesity market for the past year, making it an opportune time to review the benefits of the two most prominent obesity medications.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
pharmaphorum
JANUARY 6, 2025
Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.
PharmaVoice
JANUARY 2, 2025
A handful of innovative startups are scrambling to gain a foothold as technology improves at a rapid clip.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaTimes
JANUARY 2, 2025
New chemotherapy-free treatment shows promise for EGFR-mutated NSCLC
European Pharmaceutical Review
JANUARY 7, 2025
The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.
pharmaphorum
JANUARY 2, 2025
Roche licenses rights to a DLL3-targeted ADC from China's Innovent, hoping to bring a competitor to Amgen's lung cancer therapy Imdelltra to market
Pharmaceutical Commerce
JANUARY 6, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), provides a peek into what the association has set out to accomplish.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
MedCity News
JANUARY 6, 2025
Families USA led a letter urging the new Congress, which was sworn in on Jan. 3, to protect Medicaid. The post Over 300 Organizations Call on New Congress to Safeguard and Strengthen Medicaid appeared first on MedCity News.
PharmaTimes
JANUARY 6, 2025
EpiSwitch PSE shows promise in reducing unnecessary procedures
European Pharmaceutical Review
JANUARY 2, 2025
The National Institute for Health and Care Excellence (NICE) has recommended the first drug for NHS use to prevent cisplatin-induced hearing loss ( ototoxicity ) in children and young people between the ages of one month and 17 years old.Pedmarqsi (anhydrous sodium thiosulfate) is indicated for these children who have localised, non-metastatic, solid tumours.
pharmaphorum
JANUARY 3, 2025
CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaTech
JANUARY 2, 2025
The guidance provides recommendations for those interested in participating in FDAs Advanced Manufacturing Technologies Designation Program.
MedCity News
JANUARY 3, 2025
Health tech companies made several major funding announcements in December. Here is a list of some of the biggest funding rounds. The post 5 Notable Health Tech Funding Announcements in December appeared first on MedCity News.
PharmaTimes
JANUARY 2, 2025
MHRA urges caution over illegal medicines from beauty salons and social media
European Pharmaceutical Review
JANUARY 2, 2025
The RNA therapeutics industry stands poised for a transformative 2025, driven by breakthroughs in technology, expanding clinical applications, and a rapidly growing pipeline of innovative therapies. Following the unprecedented speed and success of mRNA-based COVID-19 vaccine development, the field has experienced a surge in investment and research to unlock the powerful potential of RNA for other therapeutic applications.
pharmaphorum
JANUARY 3, 2025
Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.
PharmaTech
JANUARY 3, 2025
The draft guidance document provides recommendations for complying with 21 CFR 211.110.
MedCity News
JANUARY 2, 2025
About 79% of digital health leaders said their companies are pursuing new investment capital in the next year, according to a recent survey from Summit Health Advisors. The post Top Priorities and Challenges for Digital Health Leaders in 2025: 5 Key Insights appeared first on MedCity News.
PharmaTimes
JANUARY 3, 2025
FDA gives green light to innovative device for liver conditions
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
JANUARY 3, 2025
The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata research team have developed an advanced injectable hydrogel
pharmaphorum
JANUARY 2, 2025
Early cancer diagnoses have risen to record levels in England, says NHS, but long waiting times for treatment threaten to undermine the gains.
PharmaVoice
JANUARY 3, 2025
Pharma companies stepped up to support The Carter Center and provide access to life-saving treatments.
MedCity News
JANUARY 6, 2025
Orbis Medicines Series A round of funding was led by New Enterprise Associates. The startup is developing oral macrocyclic drugs for targets validated by blockbuster biologic medications that must be administered by injection. The post A Startups 90M Financing for Oral Peptide Drugs Includes Backing from Eli Lilly appeared first on MedCity News.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
PharmaTimes
JANUARY 3, 2025
Government announces independent commission on social care
PharmaTech
JANUARY 2, 2025
The company is recalling one lot of PROGRAF 0.5mg (tacrolimus) and one lot of ASTAGRAF XL 0.5mg (tacrolimus extended-release) capsules because some bottles may contain empty capsules.
pharmaphorum
JANUARY 2, 2025
Hutchmed has agreed to divest its share of a non-core Chinese JV through a pair of deals that will give it a cash injection to plough into R&D.
Pharmaceutical Technology
JANUARY 2, 2025
Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years, as quality of life in these patients is compromised due to the disruptive symptoms that they experience, which include itchiness and skin inflammation.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Let's personalize your content